Endocrine Society Meets with NIH Office of Research on Women’s Health to Discuss Research Gaps & Policy Priorities

On Thursday, December 1, Janine Austin Clayton, MD, director of the NIH Office of Research on Women’s Health (ORWH) and associate director of Women’s Health Research at the NIH visited the Endocrine Society for a meeting with Endocrine Society member and associate director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Jane Reusch, MD; and the director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Judy Regensteiner, PhD.

Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society;  Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women's Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women's Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.
Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society; Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women’s Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women’s Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.

During the meeting, participants discussed research gaps and opportunities identified during the National Conference on Women’s Health Research, “Sex Differences Across the Lifespan: A Focus on Metabolism” (recently highlighted in the July Endocrine News). The group also discussed the new NIH policy on the “Consideration of Sex as a Biological Variable in NIH-funded Research.” The meeting highlighted the many synergies between the policy priorities and research interests of ORWH and the Endocrine Society.

Several specific opportunities were identified during the meeting, including working together on developing educational resources about how to appropriately consider sex as a biological variable and promoting existing resources such as the online developed by ORWH.

You may also like

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

  • Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain  

    On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…

Find more in